Raphael Mannino
2017
In 2017, Raphael Mannino earned a total compensation of $583.8K as Chief Scientific Officer at Matinas BioPharma Holdings.
Compensation breakdown
| Bonus | $70,000 |
|---|---|
| Option Awards | $275,463 |
| Salary | $238,333 |
| Total | $583,796 |
Mannino received $275.5K in option awards, accounting for 47% of the total pay in 2017.
Mannino also received $70K in bonus and $238.3K in salary.
Rankings
In 2017, Raphael Mannino's compensation ranked 11,296th out of 14,666 executives tracked by ExecPay. In other words, Mannino earned more than 23.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,296 out of 14,666 | 23rd |
Division Manufacturing | 4,427 out of 5,768 | 23rd |
Major group Chemicals And Allied Products | 1,608 out of 2,074 | 23rd |
Industry group Drugs | 1,325 out of 1,730 | 23rd |
Industry Pharmaceutical Preparations | 1,035 out of 1,329 | 22nd |
Source: SEC filing on September 24, 2019.
Mannino's colleagues
We found four more compensation records of executives who worked with Raphael Mannino at Matinas BioPharma Holdings in 2017.
2017
Roelof Rongen
Matinas BioPharma Holdings
Chief Executive Officer
2017
Jerome Jabbour
Matinas BioPharma Holdings
Chief Executive Officer
2017
Dominick DiPaolo
Matinas BioPharma Holdings
Former Senior Vice President, Quality and Regulatory Compliance
2017
Gary Gaglione
Matinas BioPharma Holdings